Editas Medicine, Inc. (EDIT) Capital expenditures 2016–2025
Editas Medicine, Inc. (EDIT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$607,000FY2025 · since FY2016: $3.5M → $607,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $607,000 | -93.1% |
| FY2024 | $8.8M | +87.0% |
| FY2023 | $4.7M | +14.6% |
| FY2022 | $4.1M | -48.4% |
| FY2021 | $8.0M | +11.4% |
| FY2020 | $7.2M | +16.1% |
| FY2019 | $6.2M | +29.7% |
| FY2018 | $4.8M | +130.9% |
| FY2017 | $2.1M | -41.1% |
| FY2016 | $3.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice